Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone

Schizophrenia Research

Volumn 60, Issue 1, 2003, Pages 81-85

  Green, Alan I ^a,b,c   Burgess, Ellen S ^a,b,c   Dawson, Ree ^a   Zimmet, Suzannah V ^a,b,c   Strous, Rael D ^a,b,c  

^a Commonwealth Research Center ^*  (United States)

^b MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alcohol; Cannabis; Clozapine; Risperidone; Schizoaffective disorder; Schizophrenia

Indexed keywords

CANNABIS; CLOZAPINE; RISPERIDONE;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOIDISM; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; AGED; ALCOHOLS; ANTIPSYCHOTIC AGENTS; CANNABIS; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 0037333663     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00231-1     Document Type: Article

References (27)

1. Abram K.M., Teplin L.A. Co-occurring disorder among mentally ill jail detainees: implications for public policy. Am. Psychol. 46:1991;1036-1045.
2. Albanese M.J., Khantzian E.J., Murphy S.I., Green A.I. Decreased substance use in chronically psychotic patients treated with clozapine. Am. J. Psychiatry. 151:1994;780-781.
3. Bartels S.J., Drake R.E., Wallach M.A., Freeman D.H. Characteristic hostility in schizophrenic outpatients. Schizophr. Bull. 17:1991;163-171.
4. Brady K., Anton R., Ballenger J.C., Lydiard R.B., Adinoff B., Salander J. Cocaine abuse among schizophrenic patients. Am. J. Psychiatry. 147:1990;1164-1167.
5. Buckley P., McCarthy M., Chapman P., Richman C., Yammamoto B. Clozapine treatment of comorbid substance abuse in patients with schizophrenia. Schizophr. Res. 36:1999;272.
6. Carey K.B. Challenges in assessing substance use patterns in persons with comorbid mental and addictive disorders. Onken L., Blaine J.D., Genser S., Horton A.M. Treatment of Drug-Dependent Individuals with Comorbid Mental Disorders. NIDA Research Monograph. vol. 172:1997;16-32 Superintendent of Documents, US Government Printing Office, Washington, DC. NIH Pub. No. 97-4172.
7. DeQuardo J.R., Carpenter C.F., Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J. Psychiatr. Res. 28:1994;267-275.
8. Drake R.E., Mueser K.T. Alcohol use disorder and severe mental illness. Alcohol Health Res. World. 20:1996;87-93.
9. Drake R.E., Xie H., McHugo G.I., Green A.I. The effects of clozapine on alcohol and drug use disorder among schizophrenic patients. Schizophr. Bull. 26:2000;441-449.
10. Green A.I., Zimmet S.V., Strous R.D., Schildkraut J.J. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv. Rev. Psychiatry. 6:1999;287-296.
11. Gupta S., Hendricks S., Kenkel A.M., Bhatoa S.C., Haffke E.A. Relapse in schizophrenia: is there a relationship to substance abuse. Schizophr. Res. 20:1996;153-156.
12. Khantzian E.J. A self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry. 142:1985;1259-1264.
13. Khantzian E.J. The self-medication hypothesis of substance use disorder: a reconsideration and recent application. Harv. Rev. Psychiatry. 4:1997;231-244.
14. Knudsen P., Vilmar T. Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr. Scand. 69:1984;162-174.
15. Krystal J.H., D'Souza D.C., Madonick S., Petrakis I.L. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenia patients. Schizophr. Res. 1999;s35-s49.
16. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorder. Arch. Gen. Psychiatry. 51:1994;273-279.
17. Marder S.R., Meibach R.C. Risperidone in the treatment of schizophrenia. Am. J. Psychiatry. 151:1994;825-835.
18. Negrete J.C., Knapp W.P., Douglas D.E., Smith W.B. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol. Med. 16:1986;515-520.
19. Owen R.R., Fischer E.P., Booth B.M., Cuffel B.J. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr. Serv. 47:1996;853-858.
20. Peralta V., Cuesta M.J. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr. Scand. 85:1992;127-130.
21. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin K.K. Comorbidity of mental disorders with alcohol and other drug abuse. J. Am. Med. Assoc. 264:1990;2511-2518.
22. Richard M.L., Liscow B.I., Perry P.J. Recent psychostimulant use in hospitalized schizophrenics. J. Clin. Psychol. 46:1985;79-83.
23. Siris S.G. Pharmacological treatment of substance-abusing schizophrenia patients. Schizophr. Bull. 16:1990;111-122.
24. Smith C.M., Barzman D., Pristach C.A. Effect of patient and family insight on compliance of schizophrenic patients. J. Clin. Pharmacol. 37:1997;147-154.
25. Swanson J.W., Holzer C.E., Ganju V.K., Jono R.T. Violence and psychiatric disorder in the community: evidence from the Epidemiological Catchment Area Survey. Hosp. Comm. Psychiatry. 41:1990;761-770.
26. Treffert D.A. Marijuana use in schizophrenia: a clear hazard. Am. J. Psychiatry. 135:1978;1213-1215.
27. Zimmet S.V., Strous R.D., Burgess E.S., Kohnstamm S., Green A.I. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J. Clin. Psychopharmacol. 20:2000;94-98.